Singapore markets open in 5 hours 32 minutes

ALX Oncology Holdings Inc. (ALXO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.93-0.45 (-6.10%)
At close: 04:00PM EDT
6.93 0.00 (0.00%)
After hours: 06:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 361.05M
Enterprise value 213.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.20
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-5.20%
S&P500 52-week change 325.69%
52-week high 317.83
52-week low 33.94
50-day moving average 313.24
200-day moving average 311.42

Share statistics

Avg vol (3-month) 3687.96k
Avg vol (10-day) 3873.2k
Shares outstanding 552.1M
Implied shares outstanding 652.1M
Float 821.39M
% held by insiders 12.06%
% held by institutions 193.94%
Shares short (15 May 2024) 43.36M
Short ratio (15 May 2024) 45.23
Short % of float (15 May 2024) 411.28%
Short % of shares outstanding (15 May 2024) 46.45%
Shares short (prior month 15 Apr 2024) 43.69M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.78%
Return on equity (ttm)-82.16%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -175M
Net income avi to common (ttm)-166.2M
Diluted EPS (ttm)-3.71
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)157.44M
Total cash per share (mrq)3.02
Total debt (mrq)16.84M
Total debt/equity (mrq)10.26%
Current ratio (mrq)5.21
Book value per share (mrq)3.27

Cash flow statement

Operating cash flow (ttm)-140.47M
Levered free cash flow (ttm)-79.92M